Corvalol drops for oral administration 25 ml
Condition: New product
981 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Peppermint leaf oil + Phenobarbital + Ethylbromizovalerianat
Release form
Drops
Composition
Active ingredient: α-bromoisovaleric acid ethyl ester Concentration of the active substance (mg): 20
Pharmacological effect
Combined drug, the action of which is due to the properties of its constituent substances. It has a sedative and antispasmodic effect. Facilitates the onset of natural sleep. The α-bromizovalerianic acid ethyl ester has a sedative (like valerian effect) and antispasmodic effect. Phenobarbital enhances the sedative effect of other components, helps reduce CNS arousal, and eases the onset of sleep.
Pharmacokinetics
Data on the pharmacokinetics of the drug is not provided.
Indications
Functional disorders of the cardiovascular system (cardialgia, sinus tachycardia, increased blood pressure); insomnia (sleep disturbance); neurotic states; vegetative lability; irritability; hypochondria syndrome; spasm of the muscles of the digestive tract (intestinal and biliary colic)
Contraindications
Hypersensitivity; severe hepatic and / or renal failure; lactation period (breastfeeding).
Precautionary measures
Do not exceed recommended doses.
Use during pregnancy and lactation
If necessary, the appointment of Corvalol during lactation should decide on the termination of breastfeeding. Use caution during pregnancy.
Dosage and administration
Inside, before eating, 15-30 drops, pre-dissolved in a small amount (30-50 ml) of water, 2-3 times / day. A single dose if necessary (for example, with tachycardia) can be increased to 40-50 drops.
Side effects
Drowsiness, dizziness, decreased ability to concentrate, allergic reactions, chronic bromine poisoning (depression, apathy, rhinitis, conjunctivitis, hemorrhagic diathesis, impaired coordination of movements); drug addiction.
Overdose
No data.
Interaction with other drugs
To date, not known.
special instructions
During the period of treatment, care must be taken when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and psychomotor reactions.